Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection

International Immunology

Volumn 22, Issue 2, 2009, Pages 81-90

  Kleinschek, Melanie A ^a,d   Müller, Uwe ^a   Schütze, Nicole ^a,e,f   Sabat, Robert ^b   Straubinger, Reinhard K ^a   Blumenschein, Wendy M ^c   McClanahan, Terrill ^c   Kastelein, Robert A ^c   Alber, Gottfried ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Schering Plough Biopharma ^*  (United States)

^d HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cryptococcus; Cytokine; Gene deficient mice; Infection; Th17

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; ANTIFUNGAL AGENTS; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 77949901522     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp117     Document Type: Article

References (44)

1. Kastelein, R. A., Hunter, C. A. and Cua, D. J. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25:221.
2. Dong, C. 2006. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6:329.
3. Levitz, S. M. 2009. Th17 cells bounce off the fungal wall. Cell Host Microbe 5:311.
4. van de Veerdonk, F. L., Marijnissen, R. J., Kullberg, B. J. et al. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5:329.
5. Uhlig, H. H., McKenzie, B. S., Hue, S. et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309.
6. Hue, S., Ahern, P., Buonocore, S. et al. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473.
7. Kullberg, M. C., Jankovic, D., Feng, C. G. et al. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485.
8. Decken, K., Kohler, G., Palmer-Lehmann, K. et al. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994.
9. Elkins, K. L., Cooper, A., Colombini, S. M., Cowley, S. C. and Kieffer, T. L. 2002. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70:1936.
10. Holscher, C., Atkinson, R. A., Arendse, B. et al. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957.
11. Lehmann, J., Bellmann, S., Werner, C., Schroder, R., Schutze, N. and Alber, G. 2001. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol. 167:5304.
12. Lieberman, L. A., Cardillo, F., Owyang, A. M. et al. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173:1887.
13. Cua, D. J., Sherlock, J., Chen, Y. et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744.
14. Levitz, S. M. and Boekhout, T. 2006. Cryptococcus: the once-sleeping giant is fully awake. FEMS Yeast Res. 6:461.
15. Casadevall, A. and Perfect, J. R. 1998. Cryptococcus neoformans. ASM Press, Washington, DC.
16. Chen, G. H., McDonald, R. A., Wells, J. C., Huffnagle, G. B., Lukacs, N. W. and Toews, G. B. 2005. The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73:1788.
17. Hoag, K. A., Lipscomb, M. F., Izzo, A. A. and Street, N. E. 1997. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17:733.
18. Huffnagle, G. B., Toews, G. B., Burdick, M. D. et al. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529.
19. Kawakami, K., Tohyama, M., Qifeng, X. and Saito, A. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1307.
20. Kawakami, K., Kohno, S., Morikawa, N., Kadota, J., Saito, A. and Hara, K. 1994. Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neoformans. Clin. Exp. Immunol. 96:230.
21. Kawakami, K., Zhang, T., Qureshi, M. H. and Saito, A. 1997. Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide. Cell Immunol. 180:47.
22. Xiao, G., Miyazato, A., Inden, K. et al. 2008. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides. Microbiol. Immunol. 52:171.
23. Kawakami, K., Koguchi, Y., Qureshi, M. H. et al. 2002. Anti-CD11 b monoclonal antibody suppresses brain dissemination of Cryptococcus neoformans in mice. Microbiol. Immunol. 46:181.
24. Oppmann, B., Lesley, R., Blom, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715.
25. Biondo, C., Midiri, A., Messina, L. et al. 2005. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur. J. Immunol. 35:870.
26. Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal Malefyt, R., Kastelein, R. A. and Cua, D. J. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202:96.
27. Blackstock, R. and Murphy, J. W. 2004. Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 30:109.
28. Kleinschek, M. A., Muller, U., Brodie, S. J. et al. 2006. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176:1098.
29. Monari, C., Kozel, T. R., Casadevall, A., Pietrella, D., Palazzetti, B. and Vecchiarelli, A. 1999. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans. Immunology 98:27.
30. Siegemund, S. and Alber, G. 2008. Cryptococcus neoformans activates bone marrow-derived conventional dendritic cells rather than plasmacytoid dendritic cells and down-regulates macrophages. FEMS Immunol. Med. Microbiol. 52:417.
31. Bava, A. J., Afeltra, J., Negroni, R. and Diez, R. A. 1995. Interferon gamma increases survival in murine experimental cryptococcosis. Rev. Inst. Med. Trop. Sao Paulo 37:391.
32. Kawakami, K., Qureshi, M.H., Zhang, T., Okamura, H., Kurimoto, M. and Saito, A. 1997. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J. Immunol. 159:5528.
33. Happel, K. I., Dubin, P. J., Zheng, M. et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761.
34. Huang, W., Na, L., Fidel, P. L. and Schwarzenberger, P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624.
35. Kelly, M. N., Kolls, J. K., Happel, K. et al. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73:617.
36. Ye, P., Garvey, P. B., Zhang, P. et al. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25:335.
37. Conti, H. R., Shen, F., Nayyar, N. et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299.
38. Zelante, T., De Luca, A., Bonifazi, P. et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695.
39. Lockhart, E., Green, A. M. and Flynn, J. L. 2006. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662.
40. Siegemund, S., Schutze, N., Schulz, S. et al. 2009. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int. Immunol. 21:555.
41. Mednick, A. J., Feldmesser, M., Rivera, J. and Casadevall, A. 2003. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur. J. Immunol. 33:1744.
42. Parham, C., Chirica, M., Timans, J. et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699.
43. Schuetze, N., Schoeneberger, S., Mueller, U., Freudenberg, M. A., Alber, G. and Straubinger, R. K. 2005. IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. Int. Immunol. 17:649.
44. Takatori, H., Kanno, Y., Watford, W. T. et al. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206:35.